About Intellectual Property IP Training IP Outreach IP for… IP and... IP in... Patent & Technology Information Trademark Information Industrial Design Information Geographical Indication Information Plant Variety Information (UPOV) IP Laws, Treaties & Judgements IP Resources IP Reports Patent Protection Trademark Protection Industrial Design Protection Geographical Indication Protection Plant Variety Protection (UPOV) IP Dispute Resolution IP Office Business Solutions Paying for IP Services Negotiation & Decision-Making Development Cooperation Innovation Support Public-Private Partnerships The Organization Working with WIPO Accountability Patents Trademarks Industrial Designs Geographical Indications Copyright Trade Secrets WIPO Academy Workshops & Seminars World IP Day WIPO Magazine Raising Awareness Case Studies & Success Stories IP News WIPO Awards Business Universities Indigenous Peoples Judiciaries Genetic Resources, Traditional Knowledge and Traditional Cultural Expressions Economics Gender Equality Global Health Climate Change Competition Policy Sustainable Development Goals Enforcement Frontier Technologies Mobile Applications Sports Tourism PATENTSCOPE Patent Analytics International Patent Classification ARDI – Research for Innovation ASPI – Specialized Patent Information Global Brand Database Madrid Monitor Article 6ter Express Database Nice Classification Vienna Classification Global Design Database International Designs Bulletin Hague Express Database Locarno Classification Lisbon Express Database Global Brand Database for GIs PLUTO Plant Variety Database GENIE Database WIPO-Administered Treaties WIPO Lex - IP Laws, Treaties & Judgments WIPO Standards IP Statistics WIPO Pearl (Terminology) WIPO Publications Country IP Profiles WIPO Knowledge Center WIPO Technology Trends Global Innovation Index World Intellectual Property Report PCT – The International Patent System ePCT Budapest – The International Microorganism Deposit System Madrid – The International Trademark System eMadrid Article 6ter (armorial bearings, flags, state emblems) Hague – The International Design System eHague Lisbon – The International System of Appellations of Origin and Geographical Indications eLisbon UPOV PRISMA Mediation Arbitration Expert Determination Domain Name Disputes Centralized Access to Search and Examination (CASE) Digital Access Service (DAS) WIPO Pay Current Account at WIPO WIPO Assemblies Standing Committees Calendar of Meetings WIPO Official Documents Development Agenda Technical Assistance IP Training Institutions COVID-19 Support National IP Strategies Policy & Legislative Advice Cooperation Hub Technology and Innovation Support Centers (TISC) Technology Transfer Inventor Assistance Program WIPO GREEN WIPO's Pat-INFORMED Accessible Books Consortium WIPO for Creators WIPO ALERT Member States Observers Director General Activities by Unit External Offices Job Vacancies Procurement Results & Budget Financial Reporting Oversight

WIPO and the Medicines Patent Pool jointly host the launch of the study: “Voluntary Licensing: Right for Health, Smart for Business”

WIPO and the Medicines Patent Pool (MPP) will jointly organize the launch of a new study, co-funded by WIPO and the Government of Canada, that demonstrates how voluntary licensing can advance access to medical technologies, while being commercially viable for biopharmaceutical companies. The study, conducted by the Boston Consulting Group (BCG), presents evidence that voluntary licensing is an effective mechanism to address global health disparities, especially in low and middle-income countries (LMICs). Using both qualitative and quantitative analyses, the study illustrates how voluntary licensing advances access to medical products across multiple geographies while offering economic benefits for biopharmaceutical companies.

Join us for a roundtable discussion with a panel of global health experts from industry, donors, governments, and UN partners on the report titled “Voluntary Licensing: Right for Health, Smart for Business”, hosted by WIPO and MPP on Wednesday, May 29th, 2024, at the sidelines of the World Health Assembly. The event will be hosted at WIPO from 14.00-15.30 hr (CEST) and can be attended in person or online.  A light lunch will precede the event at 13:00.

The study provides solid evidence that voluntary licensing can increase revenues for both innovator and generic companies, enhance access and encourage employee retention, leading to significant cost savings, with minimum costs and risks to companies.

The study also demonstrates the advantages of voluntary licensing as a mechanism to support global partnerships, local manufacturing, and equitable access to healthcare solutions.

Meeting codeWIPO-MPP/IP/GE/24
Date and venueMay 29, 2024 (Geneva, Switzerland) Hybrid
Time of sessions14:00 - 15:30 Geneva time

Other related documents

WIPO-MPP/IP/GE/24/FLYEREnglishFlyerFlyer, Complete document (pdf)
WIPO-MPP/IP/GE/24/PROGRAMEnglishProgramProgram, Complete document (pdf)
WIPO-MPP/IP/GE/24/WWW/632084EnglishReportReport, Complete document (htm)
WIPO-MPP/IP/GE/24/WWW/632085EnglishSummary presentation of the full ReportSummary presentation of the full Report, Complete document (pdf)